- 专利标题： Modified release formulations of a bupropion salt
-
申请号： US11766239申请日： 2007-06-21
-
公开(公告)号： US07585897B2公开(公告)日： 2009-09-08
- 发明人: Werner Oberegger , Fang Zhou , Paul Maes , Graham Jackson , Mohammad Ashty Saleh
- 申请人： Werner Oberegger , Fang Zhou , Paul Maes , Graham Jackson , Mohammad Ashty Saleh
- 申请人地址： BB St. Michael
- 专利权人： Biovail Laboratories International S.r.l.
- 当前专利权人： Biovail Laboratories International S.r.l.
- 当前专利权人地址： BB St. Michael
- 代理机构： Oblon, Spivak, McClelland, Maier & Neustadt, P.C.
- 主分类号： A61K31/135
- IPC分类号： A61K31/135
摘要：
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
公开/授权文献
- US20080081068A1 MODIFIED RELEASE FORMULATIONS OF A BUPROPION SALT 公开/授权日：2008-04-03
信息查询
